Home Medical OncologyQuestion

Would you use CTS5 to help you decide whether to offer prolonged adjuvant ET to HR+ breast cancer?

1 Answers

Mednet Member

Medical Oncology · Sarah Cannon Cancer Institute at Menorah Medical Center

I would

Register or Sign In to see full answer